Literature DB >> 8453641

Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.

K Y Chung1, T Mukhopadhyay, J Kim, A Casson, J Y Ro, H Goepfert, W K Hong, J A Roth.   

Abstract

Patients with primary head and neck malignancies have a 3-7% yearly incidence of second primary cancers. It is thought that these second primary cancers arise independently following exposure to a common carcinogen by a process that has been called field cancerization. Since mutations in the p53 tumor suppressor gene represent a genetic alteration occurring during the evolution of premalignant lesions to malignancies of the upper aerodigestive tract, we analyzed mutations in the p53 gene of patients with cancer of the head and neck who developed second primary tumors of the upper aerodigestive tract epithelium to test the field cancerization hypothesis. DNA was extracted from primary head and neck cancers and second primary cancers of 31 patients. DNA from exons 5-8 of the p53 gene was analyzed by the single strand conformation polymorphism technique to identify the locations of the mutations in different regions of the gene. DNA from 6 patients was also sequenced by the chain termination method to confirm the presence of mutations and determine the base substitutions. Twenty-one of the 31 patients had 1 or more p53 mutations. In all 21 cases the genetic lesions were discordant such that the presence or location of the mutations in the initial primary cancer differed from those of the second and third primary cancers. In each of the five patients with mutations in both primary tumors, the mutations occurred in different regions of the p53 gene. Of the other 16 patients, 8 had a p53 mutation in the first primary but not the subsequent primary cancer and the other 8 had no mutation in the initial primary but did have a mutation in subsequent primary cancers. Sequencing confirmed the single strand conformation polymorphism analysis and showed that 73% of the mutations were transitions. The discordant p53 mutations in second primary cancers arising in patients with primary epithelial cancer of the upper aerodigestive tract suggest that these cancers arise as independent events. These observations provide the first demonstration of a molecular basis for field cancerization effects in cancers of the upper aerodigestive tract.

Entities:  

Mesh:

Year:  1993        PMID: 8453641

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Infrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high-incidence area of Southwest China.

Authors:  Xiu-Jie Wang; Shu-Lan Yuan; Chang-Ping Li; Naoko Iida; Hideaki Oda; Shigetoshi Aiso; Takatoshi Ishikawa
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

3.  Determination of primary foci of metastatic tumors by p53 mutational analysis in intraesophageal multiple carcinomas.

Authors:  S Kuwabara; T Nishimaki; Y Ajioka; S Komukai; T Suzuki; H Watanabe; K Hatakeyama
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

4.  Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening.

Authors:  A K El-Naggar; L Mao; G Staerkel; M M Coombes; S L Tucker; M A Luna; G L Clayman; S Lippman; H Goepfert
Journal:  J Mol Diagn       Date:  2001-11       Impact factor: 5.568

5.  Knockdown of IARS2 suppressed growth of gastric cancer cells by regulating the phosphorylation of cell cycle-related proteins.

Authors:  Zheng Fang; Xingyu Wang; Qiang Yan; Shangxin Zhang; Yongxiang Li
Journal:  Mol Cell Biochem       Date:  2017-10-25       Impact factor: 3.396

6.  In vivo infiltration of mononuclear cells in squamous cell carcinoma of the head and neck correlates with the ability to expand tumour-infiltrating T cells in vitro and with the expression of MHC class I antigens on tumour cells.

Authors:  J Hald; N Rasmussen; M H Claesson
Journal:  Cancer Immunol Immunother       Date:  1994-12       Impact factor: 6.968

7.  An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

Authors:  Charles M Rudin; Ezra E W Cohen; Vassiliki A Papadimitrakopoulou; Sol Silverman; Wendy Recant; Adel K El-Naggar; Kirsten Stenson; Scott M Lippman; Waun Ki Hong; Everett E Vokes
Journal:  J Clin Oncol       Date:  2003-11-03       Impact factor: 44.544

Review 8.  Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.

Authors:  V A Papadimitrakopoulou; D M Shin; W K Hong
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

Review 9.  Molecular staging of head and neck squamous carcinoma.

Authors:  J A Brennan; D Sidransky
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

Review 10.  Biological staging of head and neck cancer and its role in developing effective treatment strategies.

Authors:  W M Lydiatt; S P Schantz
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.